Brazil Confirms Death of Volunteer in COVID-19 Vaccine Trial
October 22, 2020
(Medscape) – The Brazilian National Health Surveillance Agency (Anvisa) announced today that it is investigating data received on the death of a volunteer in a clinical trial of the COVID-19 vaccine developed by Oxford University and the pharmaceutical company AstraZeneca. In an email sent to Medscape Medical News, the agency states that it was formally informed of the death on October 19. It has already received data regarding the investigation of the case, which is now being conducted by the Brazilian International Security Assessment Committee.